Log In
Print
BCIQ
Print
Print this Print this
 

ITI-214

  Manage Alerts
Collapse Summary General Information
Company Intra-Cellular Therapies Inc.
DescriptionPhosphodiesterase-1 (PDE-1) inhibitor
Molecular Target Phosphodiesterase-1 (PDE-1)
Mechanism of ActionPhosphodiesterase-1 (PDE-1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSchizophrenia
Indication DetailsTreat cognitive impairment associated with schizophrenia
Regulatory Designation

Partner

Takeda Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today